Insights That Inspire

Expert Opinions

Thought-provoking perspectives from leading experts, thought leaders, and innovators shaping the future of healthcare and nutritional medicine.
April 13, 2026

Enteral & Parenteral Nutrition in Inflammatory Bowel Disease: A Bibliometric Analysis

Op Ed: Research output on nutritional support in IBD has increased, with a shift towards enteral routes. Background & Rationale Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, frequently presents with nutritional deficiencies due to inflammation-induced malabsorption, increased metabolic demands, and diarrhoea. Nutritional support, both enteral and parenteral, plays a crucial role in […]

April 12, 2026

Patient Knowledge and Awareness of Inflammatory Bowel Disease Globally

Op Ed:Knowledge gaps persist across regions, impacting patient experience and disease management. Background & Rationale Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is an increasingly prevalent chronic inflammatory condition worldwide. Effective disease management relies not only on pharmacological interventions but also on patient understanding of their condition. Suboptimal patient knowledge can lead […]

April 11, 2026

The German IBD Competence Network: 25 Years of Collaborative Care

Op Ed: A national network improved IBD care through sustained collaboration and data collection. Background & Rationale Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, demands a multidisciplinary approach to optimise patient outcomes. Historically, IBD care has been fragmented, lacking seamless integration between specialist centres, general practitioners, and other healthcare providers. The German […]

April 10, 2026

Guideline for the Treatment of Ulcerative Colitis and Crohn’s Disease in Adult Patients

Op Ed: A national consensus guideline provides recommendations for the management of IBD in Chile. Background & Rationale Inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), presents a growing health challenge. Its incidence is increasing globally, including in Chile, necessitating standardised, evidence-based management strategies. Prior to this work, Chile lacked a […]

April 10, 2026

Guideline for the Treatment of Ulcerative Colitis and Crohn’s Disease in Adult Patients

Clinical Review: National guidelines were developed for the management of inflammatory bowel disease in Chile. Background & Rationale Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, presents a growing healthcare challenge worldwide, including in Chile. Prior to this work, Chile lacked nationally endorsed, evidence-based guidelines for IBD management. Existing international guidelines do not […]

April 10, 2026

Immunisation Adherence in IBD Patients Receiving Biologic Therapy

Op Ed: Immunisation rates were suboptimal in patients with IBD on biologic treatment. Background & Rationale Patients with inflammatory bowel disease (IBD) receiving immunosuppressive therapies, including biologic agents, are at increased risk of infection. Consequently, adherence to recommended immunisation schedules is paramount to mitigate this risk. However, immunosuppression may also impair the immunogenicity of vaccines, […]

April 10, 2026

Rapid Dietary Intervention Improves Symptomatic Crohn’s Disease: A Randomized Controlled Trial

Op Ed: A 5-day modified diet significantly decreased endoscopic and subjective disease activity. Background & Rationale Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract characterised by periods of remission and relapse. Current pharmacological therapies, while effective for many, do not consistently achieve sustained remission and are often associated with adverse effects. Increasing […]

April 10, 2026

A 5-Day Dietary Intervention Improved Symptoms in Crohn’s Disease

Op Ed: A short-term, low-residue diet demonstrated rapid symptomatic benefit in Crohn’s disease. Background & Rationale Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract characterised by periods of remission and relapse. Current pharmacological treatments, while effective for inducing and maintaining remission, do not always provide rapid symptomatic relief, leaving patients experiencing substantial […]

×
×